Global Analysis of Ebola Disease

Expenditure on Prevention and Containment to Soar towards $5.9 Billion by End of 2016

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll nearing 5,000. The Ebola market is segmented by diagnostics and pharmaceuticals, and the diagnostics market includes both molecular methods and immunodiagnostics tests, of which a 2-year potential-revenue forecast is provided. Molecular methods will see wide adoption for the specificity, sensitivity, and rapidity of the tests. Competitive landscape and companies to watch chapters are provided.

Table of Contents

Executive SummaryKey FindingsMarket OverviewWhat is Ebola?Timeline of Key Events Scope and SegmentationKey Questions This Study Will AnswerCEO’s PerspectiveSpread of EbolaMethodology, Assumptions, and DefinitionsMethodology, Assumptions, and Definitions (continued)Methodology, Assumptions, and Definitions (continued)Methodology, Assumptions, and Definitions (continued)Projected Ebola Prevalence (Global) Ebola Market for Molecular Tests (Global) Ebola Market for Immunodiagnostic Tests (Global) Global Expenditure Forecast by Mild Cases of EbolaGlobal Expenditure Forecast by Severe Cases of EbolaGlobal Expenditure Forecast Comparing Mild and Severe Ebola Cases Competitive LandscapeCompetitive Landscape for Pipeline Vaccines and DrugsCompetitive Landscape for Diagnostic ProductsCompanies to WatchEbola DiagnosticsEbola Drugs and VaccinesLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition—Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.